Boron magnetic resonance imaging (MRI) and spectroscopy (MRS) are bein
g developed for use in boron neutron capture therapy (BNCT). With cont
inued development, boron MRI may be used to locate BNCT agents in vivo
, evaluate the pharmacokinetics of BNCT agents, and aid in treatment p
lanning.